Article
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Oncotarget - 8 Nov 2016
Roodakker Kenney R, Elsir Tamador, Edqvist Per-Henrik D, Hägerstrand Daniel, Carlson Joseph, Lysiak Malgorzata, Henriksson Roger, Pontén Fredrik, Rosell Johan, Söderkvist Peter, Stupp Roger, Tchougounova Elena, Nistér Monica, Malmström Annika, Smits Anja
Abstract excerpt
PROX1 is a transcription factor with an essential role in embryonic development and determination of cell fate. In addition, PROX1 has been ascribed suppressive as well as oncogenic roles in several human cancers, including brain tumors. In this study we explored the correlation between PROX1 expression and patient survival in high-grade astrocytomas. For this purpose, we analyzed protein expression in tissue...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
